Tuesday, 3 June 2014
Pharmacoeconomic Guidelines update
ISPOR’s Pharmacoeconomic Guidelines resource has now added Slovenian Guidelines. In addition, Pharmacoeconomic Guidelines for New Zealand have been updated to show discounting at 8% and the requirements for a financial impact statement. Other recent revisions have been made to the guidelines for Finland, Hungary, Belgium, Germany, The Netherlands, Portugal, United States, and the Slovak Republic.